236 results on '"Swaminathan, Aparna"'
Search Results
2. Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
3. Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis
4. Quality of Life in Adults with Chronic Cough: A Mixed Methods Study Informing the Development of a Quantitative Patient Preference Study
5. Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
6. Hyperpolarized 129Xe MRI and spectroscopy of gas exchange abnormalities in chronic hypersensitivity pneumonitis
7. Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
8. Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition
9. Lung transplantation during acute exacerbations of interstitial lung disease and post-transplant survival
10. Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation
11. A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
12. SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
13. Pregnancy Outcomes in Patients With Interstitial Lung Disease
14. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry
15. Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants
16. Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages
17. Patient preferences for the treatment of chronic cough: a discrete choice experiment
18. Quality of Life in Adults with Chronic Cough: A Mixed Methods Study Informing the Development of a Quantitative Patient Preference Study
19. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
20. EVALUATION OF CONTENT VALIDITY OF A NEW EXPOSURE ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASES
21. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES IN THE ILD-PRO REGISTRY BY TIME BETWEEN DIAGNOSIS AND ENROLLMENT
22. ASSOCIATION OF HRCT PATTERNS AND TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
23. Characteristics of patients with progressive fibrosing ILDs in the ILD-PRO Registry
24. External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources
25. Mine Smartness and the Community Voice in Mine-Risk Education: Lessons from Afghanistan and Angola
26. Treatment-related biomarkers in pulmonary hypertension patients on oral therapies
27. Functional gas exchange measures on 129Xe MRI and spectroscopy are associated with age, sex, and BMI in healthy subjects.
28. Integrative genomics important to understand host–pathogen interactions.
29. Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs
30. SARS-CoV-2 Variants of Concern and Variations within Their Genome Architecture: Does Nucleotide Distribution and Mutation Rate Alter the Functionality and Evolution of the Virus?
31. The impact of a measurement and feedback intervention on blood pressure control in ambulatory cardiology practice
32. 11 - Interactions shaping the interactome: genome surveillance inclusive of host–pathogen
33. Chapter 9 - A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
34. PATIENT PREFERENCES FOR TREATMENT OF CHRONIC COUGH: PRELIMINARY FINDINGS FROM A DISCRETE CHOICE EXPERIMENT
35. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (ILD): DATA FROM THE ILD-PRO REGISTRY
36. Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction
37. CHARACTERISTICS AND PREVALENCE OF ENVIRONMENTAL AND OCCUPATIONAL EXPOSURES AMONG PATIENTS WITH INTERSTITIAL LUNG DISEASES
38. Integrative genomics important to understand host–pathogen interactions
39. LncRNAs harbouring regulatory motifs within repeat elements modulate immune response towards COVID‐19 disease severity and clinical outcomes
40. Pediatric School Outreach: Clinical Needs of an Urban Student Population
41. Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry
42. Human‐host transcriptomic analysis reveals unique early innate immune responses in different sub‐phenotypes of COVID‐19
43. SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key
44. Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?
45. Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?
46. Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
47. Pregnancy Outcomes in Patients with Interstitial Lung Disease
48. Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels
49. Treatment-Related Biomarkers in Pulmonary Hypertension
50. OUTCOMES OF PATIENTS ACROSS THE SPECTRUM OF PULMONARY HYPERTENSION GROUPS PRESCRIBED INHALED TREPROSTINIL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.